-
Neuronetics Prices of $75 Million Public Offering of Common Stock
Post on 1/28/21
-
Neuronetics Proposes Public Offering of Common Stock
Post on 1/28/21
-
Helius Medical Technologies Prices of $9.6 Million Underwritten Public Offering
Post on 1/28/21
-
Ortho Clinical Diagnostics Prices IPO
Post on 1/27/21
-
Citius Pharmaceuticals Closes of $20.0 Million Private Placement
Post on 1/27/21
-
Comcast Ties Up With WWE in Peacock Streaming Deal
Post on 1/27/21
-
Why Pfizer Will Make More Money Than Originally Expected in 2021
Post on 1/27/21
-
Should You Buy Johnson & Johnson Stock Before Its Big Coronavirus Vaccine News?
Post on 1/27/21
-
Is Pfizer A Great Dividend Stock?
Post on 1/27/21
-
Here's Why Investors Cheered Johnson & Johnson's Q4 Results
Post on 1/27/21
-
Johnson & Johnson Rises on Q4 Beats, Coronavirus Vaccine Hopes
Post on 1/27/21
-
Johnson & Johnson Reports 2020 Fourth-Quarter And Full Year Results
Post on 1/26/21
-
VYNE Therapeutics Sale of $50 Million Registered Direct Offering of Common Stock
Post on 1/26/21
-
Pacira BioSciences Equity Invest in GeneQuine Biotherapeutics
Post on 1/26/21
-
States that Have the Fewest COVID-19 Restrictions – Updated WalletHub Study
Post on 1/26/21
-
Why Pfizer's Future Looks Better in 2021
Post on 1/26/21
-
Merck Gives Up on Coronavirus Vaccines
Post on 1/26/21
-
Caladrius Biosciences Closes $25.0 Million Private Placement
Post on 1/25/21
-
OncoSec Medical Closes $42.0 Million Public Offering of Common Stock
Post on 1/25/21
-
INOVIO Closes Public Offering of Common Stock
Post on 1/25/21
-
Citius Pharmaceuticals Announces $20.0 Million Private Placement
Post on 1/25/21
-
Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development of Two Investigational Therapeutic Candidates
Post on 1/25/21
-
Advaxis Reports Fiscal Year 2020 Financial Results and Provides a Business Update
Post on 1/25/21
-
What Kind of Deals Is Pfizer Planning for the Next Few Years?
Post on 1/25/21
-
Why Pfizer's Future Looks Better in 2021
Post on 1/25/21